SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-001668
Filing Date
2021-02-25
Accepted
2021-02-24 19:24:20
Documents
107
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clvs-20201231x10k.htm   iXBRL 10-K 4056947
2 EX-10.40 clvs-20201231xex10d40.htm EX-10.40 527029
3 EX-23.1 clvs-20201231xex23d1.htm EX-23.1 4350
4 EX-31.1 clvs-20201231xex31d1.htm EX-31.1 15863
5 EX-31.2 clvs-20201231xex31d2.htm EX-31.2 15899
6 EX-32.1 clvs-20201231xex32d1.htm EX-32.1 6476
7 EX-32.2 clvs-20201231xex32d2.htm EX-32.2 6513
8 GRAPHIC clvs-20201231x10k006.jpg GRAPHIC 80246
9 GRAPHIC clvs-20201231x10k008.jpg GRAPHIC 57502
  Complete submission text file 0001558370-21-001668.txt   16328982

Data Files

Seq Description Document Type Size
10 EX-101.SCH clvs-20201231.xsd EX-101.SCH 82049
11 EX-101.CAL clvs-20201231_cal.xml EX-101.CAL 115352
12 EX-101.DEF clvs-20201231_def.xml EX-101.DEF 274360
13 EX-101.LAB clvs-20201231_lab.xml EX-101.LAB 817300
14 EX-101.PRE clvs-20201231_pre.xml EX-101.PRE 579779
15 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20201231x10k_htm.xml XML 3190063
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 21675674
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences